five dose regimens of 2',3'-dideoxycytidine ( ddc ) were administered , intravenously for 2 weeks then orally for 4 or more weeks , to 20 patients with acquired immunodeficiency syndrome ( aids ) or aids-related complex ( arc ) .
C0012132
dideoxycytidine
C0001175
aids